Jupiter Neurosciences, Inc.
JUNS
$0.64
$0.00761.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13,126.32% | -- | -- | -87.11% | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 293,500.00% | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 16,103.14% | -- | -- | -- | -- |
|
|
|||||
| Total Current Assets | 16,103.14% | -- | -- | -- | -- |
| Net Property, Plant & Equipment | -40.05% | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 38,913.16% | -- | -- | -- | -- |
| Total Assets | 4,073.89% | -- | -- | -- | -- |
|
|
|||||
| Total Accounts Payable | 47.07% | -- | -- | -- | -- |
| Total Accrued Expenses | -22.43% | -- | -- | -- | -- |
| Short-term Debt | -92.76% | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.94% | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -99.84% | -- | -- | -- | -- |
| Total Other Current Liabilities | -99.84% | -- | -- | -- | -- |
| Total Current Liabilities | -65.19% | -- | -- | -- | -- |
|
|
|||||
| Total Current Liabilities | -65.19% | -- | -- | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -92.76% | -- | -- | -- | -- |
| Capital Leases | -70.27% | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -65.88% | -- | -- | -- | -- |
|
|
|||||
| Common Stock & APIC | 69.81% | -- | -- | -- | -- |
| Retained Earnings | -10.34% | -- | -- | -- | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 171.91% | -- | -- | 15.73% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 171.91% | -- | -- | 15.73% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 171.91% | -- | -- | 15.73% | -- |
|
|
|||||